Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.
Jiang E, Qian K, Wang L, Yang D, Shao Y, Hu L, Li Y, Yao C, Han M, Hou X, Liu D. Jiang E, et al. BMC Med. 2024 Nov 25;22(1):555. doi: 10.1186/s12916-024-03782-5. BMC Med. 2024. PMID: 39587570 Free PMC article. Clinical Trial.
The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trial.
Chen S, Zhang X, Niu T, Xu Y, Gao G, Fan S, Zhou Z, Zhou F, Li F, Liu L, Yang W, Liu Q, Zhang X, He Y, Feng S, Han M, Zhai W, Jiang E. Chen S, et al. Among authors: jiang e. Am J Cancer Res. 2024 Oct 15;14(10):4969-4978. doi: 10.62347/SKXB3242. eCollection 2024. Am J Cancer Res. 2024. PMID: 39553212 Free PMC article.
Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP, Lu PH, Wu DP, Huang H, Jiang EL, Liu DH, Cao WJ, Zhang X, Fu YW, Li NN, Chen XC, Zhu XY, Liu QF, Xia LH, Zhang YC, Xu YJ, Li FC, Hu J, Liu SX, Liu RR, Ma XD, Tang XW, Luo Y, Zhang XH, Huang XJ; Chinese Blood and Marrow Transplantation Registry Group. Xu LP, et al. Among authors: jiang el. Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02438-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39548309 No abstract available.
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China.
Li L, Chen Y, Chen T, Xu Y, Zhu P, Shi J, Zhai W, Zhao Y, Xu Y, Lai X, Yu J, Liu L, Song X, Yang T, Lu Y, Yang K, Feng Y, Ni X, Lan J, Qiu X, Zhang Y, Jiang S, Huang H, Jiang E, Zhang X, Luo Y. Li L, et al. Among authors: jiang e. Bone Marrow Transplant. 2024 Nov 8. doi: 10.1038/s41409-024-02454-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39516707
616 results